The Principal Scientist of Oligonucleotide Development at Dyne Therapeutics will lead the strategy for chemical synthesis of PMO and modified ASO molecules, overseeing both internal execution and collaboration with CDMOs. This role involves driving process excellence, defining analytical strategies, and contributing to regulatory submissions while ensuring robust and scalable manufacturing processes. The position requires a strong presence on-site in Waltham, MA, 4-5 days a week.
See how your résumé matches this role — and tailor it from what actually gets interviews.